a. Mean age in years. b. For 6 treatment-naive patients, MS type was not specified. c. Median EDSS score; this information was not available for 7 treatment-naive patients and 6 IFN-β-treated patients
Clinical Events and Laboratory Tests Analysis File (July 2024). Data updated in 2024 in DASH to include the follow-up time points through the final participant visit in 2020. Study Description The PHA
Presence of any CDC Clinical Category C conditions at baseline or since last study visit (HIV Disease Classification CRF) Study Description Describes the demographic, clinical, immunologic, and virolo
